Not Yet Recruiting
Befotertinib Plus Chemotherapy With an MRD-guided Adaptive Strategy for Treatment Escalation and Response Optimization in EGFR-mutated NSCLC Patients
NCT07709585
- Conditions
- Advanced Non-small Cell Lung Cancer (NSCLC), EGFR Exon 19 Deletion Mutation, EGFR Exon 21 L858R Mutation, +6 more
- Locations
-
- Guangdong Provincial Hospital of Chinese Medicine Guangzhou, Guangdong, China